195 related articles for article (PubMed ID: 20530733)
21. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
22. Lipoproteins abnormalities in obese insulin-resistant dogs.
Bailhache E; Nguyen P; Krempf M; Siliart B; Magot T; Ouguerram K
Metabolism; 2003 May; 52(5):559-64. PubMed ID: 12759884
[TBL] [Abstract][Full Text] [Related]
23. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
[TBL] [Abstract][Full Text] [Related]
24. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
Tudurí E; Beiroa D; Porteiro B; López M; Diéguez C; Nogueiras R
Diabetes Obes Metab; 2015 Aug; 17(8):789-99. PubMed ID: 25962313
[TBL] [Abstract][Full Text] [Related]
25. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
26. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
Hodson L; Bickerton AS; McQuaid SE; Roberts R; Karpe F; Frayn KN; Fielding BA
Diabetes; 2007 Oct; 56(10):2433-41. PubMed ID: 17601988
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
[TBL] [Abstract][Full Text] [Related]
28. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet.
van den Hoek AM; Heijboer AC; Corssmit EP; Voshol PJ; Romijn JA; Havekes LM; Pijl H
Diabetes; 2004 Aug; 53(8):1949-52. PubMed ID: 15277371
[TBL] [Abstract][Full Text] [Related]
29. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
[TBL] [Abstract][Full Text] [Related]
30. A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-alpha protein concentration in ApoE-3*Leiden mice.
Muurling M; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
J Nutr; 2003 Nov; 133(11):3350-5. PubMed ID: 14608043
[TBL] [Abstract][Full Text] [Related]
31. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.
Knauf C; Cani PD; Ait-Belgnaoui A; Benani A; Dray C; Cabou C; Colom A; Uldry M; Rastrelli S; Sabatier E; Godet N; Waget A; Pénicaud L; Valet P; Burcelin R
Endocrinology; 2008 Oct; 149(10):4768-77. PubMed ID: 18556349
[TBL] [Abstract][Full Text] [Related]
32. Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice.
den Boer MA; Voshol PJ; Schröder-van der Elst JP; Korsheninnikova E; Ouwens DM; Kuipers F; Havekes LM; Romijn JA
Endocrinology; 2006 Oct; 147(10):4553-8. PubMed ID: 16709607
[TBL] [Abstract][Full Text] [Related]
33. A low-fat diet has a higher potential than energy restriction to improve high-fat diet-induced insulin resistance in mice.
Muurling M; Jong MC; Mensink RP; Hornstra G; Dahlmans VE; Pijl H; Voshol PJ; Havekes LM
Metabolism; 2002 Jun; 51(6):695-701. PubMed ID: 12037721
[TBL] [Abstract][Full Text] [Related]
34. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of glucagon-like peptide-1 on microvascular recruitment and glucose metabolism in short- and long-term insulin resistance.
Sjøberg KA; Rattigan S; Jeppesen JF; Lundsgaard AM; Holst JJ; Kiens B
J Physiol; 2015 May; 593(9):2185-98. PubMed ID: 25688993
[TBL] [Abstract][Full Text] [Related]
36. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
[TBL] [Abstract][Full Text] [Related]
37. GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes.
Tomas E; Stanojevic V; Habener JF
Horm Metab Res; 2010 Aug; 42(9):657-62. PubMed ID: 20645222
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
[TBL] [Abstract][Full Text] [Related]
39. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity.
Cabou C; Campistron G; Marsollier N; Leloup C; Cruciani-Guglielmacci C; Pénicaud L; Drucker DJ; Magnan C; Burcelin R
Diabetes; 2008 Oct; 57(10):2577-87. PubMed ID: 18633100
[TBL] [Abstract][Full Text] [Related]
40. GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
Taher J; Baker CL; Cuizon C; Masoudpour H; Zhang R; Farr S; Naples M; Bourdon C; Pausova Z; Adeli K
Mol Metab; 2014 Dec; 3(9):823-33. PubMed ID: 25506548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]